Market Overview:
The US generic injectables market reached a value of US$ 13.7 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Generic injectables refer to bioequivalents of branded drugs that are not protected by patents. They are used for rapidly transporting the drug into the body, bypassing the first-pass metabolism. Since they have a similar quality, dosage, strength, effect and active ingredient, generic injectables are as safe and effective as innovator injectables. They are widely used in the United States on account of the rise in the prevalence of lifestyle ailments due to sedentary lifestyles, non-nutritive diet and aging population. They are utilized in the treatment of diseases such as cancer, diabetes, osteoporosis, osteoarthritis, rheumatoid arthritis, respiratory and cardiovascular disorders.
The US is witnessing a rise in the demand for generic injectables on account of increasing investment by the US Government for the development of generic drugs. It is focusing on promoting generic injectables to reduce healthcare expenditure in the country. Further, drug shortages in confluence with speedy approvals by the USFDA are expected to boost the manufacturing of these drugs. Moreover, several branded injectables firms are also anticipated to lose their patient protection in the upcoming years, thereby offering numerous remunerative opportunities to the generic injectables manufacturers.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the US generic injectables market, along with forecasts at the regional and country level from 2021-2026. Our report has categorized the market based on therapeutic area, containers and distribution channel.
Breakup by Therapeutic Area:
- Oncology
- Anesthesia
- Anti-Infectives
- Parenteral Nutrition
- Cardiovascular
The report finds that the oncology segment exhibits dominance in the market as injectables are used to treat different types of cancers. It is followed by anti-infectives, cardiovascular, parenteral nutrition and anesthesia.
Breakup by Containers:
- Vials
- Ampoules
- Premix
- Prefilled Syringes
Currently, vials account for the majority of the total market share as they are flexible, easy to dispose of and cost-effective. They are followed by premix, prefilled syringes and ampoules.
Breakup by Distribution Channel:
- Hospitals
- Retail Pharmacy
At present, hospitals represent the largest segment as the injectables for oncology, anesthesia, and anti-infectives cannot be administrated without medical assistance.
Competitive Landscape:
The market is highly concentrated in nature with the presence of only a few top manufacturers who compete against one another in terms of prices and quality.
Key Questions Answered in this Report:
- How has the US generic injectables market performed so far and how will it perform in the coming years?
- What are the major therapeutic areas in the US generic injectables industry?
- What has been the impact of COVID-19 on the US generic injectables industry?
- What are the several containers used in the US generic injectables industry?
- What are the major distribution channels in the US generic injectables industry?
- What are the various stages in the value chain of the US generic injectables industry?
- What are the key driving factors and challenges in the US generic injectables industry?
- What is the structure of the US generic injectables industry and who are the key players?
- What is the degree of competition in the US generic injectables industry?
- What are the profit margins in the US generic injectables industry?
- What are the key requirements for setting up generic injectables manufacturing plant?
- How are generic injectables manufactured?
- What are the various unit operations involved in generic injectables manufacturing plant?
- What is the total size of land required for setting up generic injectables manufacturing plant?
- What are the machinery requirements for setting up generic injectables manufacturing plant?
- What are the raw material requirements for setting up generic injectables manufacturing plant?
- What are the packaging requirements for generic injectables?
- What are the transportation requirements for generic injectables?
- What is the time required to break-even?
1 Preface
2 Scope and Methodology
2.1 Objectives of the study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drug Industry
5.1 Market Overview
5.2 Market Performance
5.2.1 Sales Volume
5.2.2 Sales Value
5.3 Market Breakup by Country
5.4 Market Forecast
6 US Generic Drug Industry
6.1 Market Overview
6.2 Market Performance
6.2.1 Sales Volume
6.2.2 Sales Value
6.3 Market Forecast
7 US Generic Drug Industry – Drug Delivery Systems
7.1 Orals
7.2 Injectables
7.3 Dermal/Topical
7.4 Inhalers
8 Global Generic Injectables Industry
8.1 Market Overview
8.2 Market Performance
8.3 Market Breakup by Region
8.4 Market Breakup by Therapeutic Area
8.5 Market Breakup by Containers
8.6 Market Breakup by Distribution Channel
8.7 Market Share of Key Players
8.8 Market Forecast
9 US Generic Injectables Industry
9.1 Market Overview
9.2 Market Performance
9.3 Impact of COVID-19
9.4 Market by Therapeutic Area
9.5 Market by Containers
9.6 Market by Distribution Channel
9.7 Market Share of Key Players
9.8 Market Forecast
9.9 SWOT Analysis
9.9.1 Overview
9.9.2 Strength
9.9.3 Weakness
9.9.4 Opportunity
9.9.5 Threat
9.10 Value Chain Analysis
9.11 Porters Five Forces Analysis
9.11.1 Overview
9.11.2 Bargaining Power of Buyers
9.11.3 Bargaining Power of Suppliers
9.11.4 Degree of Rivalry
9.11.5 Threat of New Entrants
9.11.6 Threat of Substitutes
9.12 Key Success and Risk Factors
10 US Generic Injectables Market: Breakup by Therapeutic Area
10.1 Oncology
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Anesthesia
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Anti-infectives
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Parenteral Nutrition
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Cardiovascular
10.5.1 Market Trends
10.5.2 Market Forecast
11 US Generic Injectables Market: Breakup by Containers
11.1 Vials
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Ampoules
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Premix
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Prefilled Syringes
11.4.1 Market Trends
11.4.2 Market Forecast
12 US Generic Injectables Market: Breakup by Distribution Channel
12.1 Hospitals
12.1.1 Market Trends
12.1.2 Market Forecast
12.2 Retail Pharmacy
12.2.1 Market Trends
12.2.2 Market Forecast
13 US Generic Injectables Market: Competitive Landscape
13.1 Competitive Structure
13.2 Market Breakup by Key Players
14 Generic Injectables Manufacturing Process
14.1 Product Overview
14.2 Detailed Process Flow
14.3 Various Types of Unit Operations Involved
14.4 Mass Balance and Raw Material Requirements
15 Project Details, Requirements and Costs Involved
15.1 Land, Location and Site Development
15.2 Construction Requirements
15.3 Machinery Requirements
15.4 Machinery Pictures
15.5 Raw Materials Requirements
15.6 Raw Material and Final Product Pictures
15.7 Packaging Requirements
15.8 Transportation Requirements
15.9 Product Pricing and Margins Across Various Levels of the Supply Chain
16 Key Players Profiles
List of Figures
Figure 1: Global: Generic Drug Market: Sale Volume (in Billion Standard Units), 2015-2020
Figure 2: Global: Generic Drug Market: Sale Value (in Billion US$), 2015-2020
Figure 3: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2020
Figure 4: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2020
Figure 5: Global: Generic Drug Market Forecast: Sale Volume (in Billion Standard Units), 2021-2026
Figure 6: Global: Generic Drug Market Forecast: Sale Value (in Billion US$), 2021-2026
Figure 7: US: Generic Drug Market: Sale Volume (in Billion Standard Units), 2015-2020
Figure 8: US: Generic Drug Market: Sale Value (in Billion US$), 2015-2020
Figure 9: US: Generic Drug Market Forecast: Sale Volume (in Billion Standard Units), 2021-2026
Figure 10: US: Generic Drug Market Forecast: Sale Value (in Billion US$), 2021-2026
Figure 11: US: Generic Drug Market: Drug Delivery System (in %), 2020
Figure 12: Global: Generic Injectables Market: Sale Value (in Billion US$), 2015-2020
Figure 13: Global: Generic Injectables Market: Breakup by Region (in %), 2020
Figure 14: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2020
Figure 15: Global: Generic Injectables Market: Breakup by Container (in %), 2020
Figure 16: Global: Generic Injectables Market: Breakup by Distribution Channels (in %), 2020
Figure 17: Global: Generic Injectables Market: Share of Key Players (in %), 2020
Figure 18: Global: Generic Injectables Market Forecast: Sale Value (in Billion US$), 2021-2026
Figure 19: US: Generic Injectables Market: Sale Value (in Billion US$), 2015-2020
Figure 20: US: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2020
Figure 21: US: Generic Injectables Market: Breakup by Container (in %), 2020
Figure 22: US: Generic Injectables Market: Breakup by Distribution Channels (in %), 2020
Figure 23: US: Generic Injectables Market: Breakup by Key Players (in %), 2020
Figure 24: US: Generic Injectables Market Forecast: Sale Value (in Billion US$), 2021-2026
Figure 25: US: Generic Injectables Industry: SWOT Analysis
Figure 26: US: Generic Injectables Industry: Value Chain Analysis
Figure 27: US: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 28: US: Generic Injectables (Oncology) Market: Sale Value (in Million US$), 2015 & 2020
Figure 29: US: Generic Injectables (Oncology) Market Forecast: Sale Value (in Million US$), 2021-2026
Figure 30: US: Generic Injectables (Anesthesia) Market: Sale Value (in Million US$), 2015 & 2020
Figure 31: US: Generic Injectables (Anesthesia) Market Forecast: Sale Value (in Million US$), 2021-2026
Figure 32: US: Generic Injectables (Anti-infectives) Market: Sale Value (in Million US$), 2015 & 2020
Figure 33: US: Generic Injectables (Anti-infectives) Market Forecast: Sale Value (in Million US$), 2021-2026
Figure 34: US: Generic Injectables (Parenteral Nutrition) Market: Sale Value (in Million US$), 2015 & 2020
Figure 35: US: Generic Injectables (Parenteral Nutrition) Market Forecast: Sale Value (in Million US$), 2021-2026
Figure 36: US: Generic Injectables (Cardiovascular) Market: Sale Value (in Million US$), 2015 & 2020
Figure 37: US: Generic Injectables (Cardiovascular) Market Forecast: Sale Value (in Million US$), 2021-2026
Figure 38: US: Generic Injectables (Vials) Market: Sale Value (in Million US$), 2015 & 2020
Figure 39: US: Generic Injectables (Vials) Market Forecast: Sale Value (in Million US$), 2021-2026
Figure 40: US: Generic Injectables (Ampoules) Market: Sale Value (in Million US$), 2015 & 2020
Figure 41: US: Generic Injectables (Ampoules) Market Forecast: Sale Value (in Million US$), 2021-2026
Figure 42: US: Generic Injectables (Premix) Market: Sale Value (in Million US$), 2015 & 2020
Figure 43: US: Generic Injectables (Premix) Market Forecast: Sale Value (in Million US$), 2021-2026
Figure 44: US: Generic Injectables (Prefilled Syringes) Market: Sale Value (in Million US$), 2015 & 2020
Figure 45: US: Generic Injectables (Prefilled Syringes) Market Forecast: Sale Value (in Million US$), 2021-2026
Figure 46: US: Generic Injectables Market: Sales through Hospitals (in Million US$), 2015 & 2020
Figure 47: US: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2021-2026
Figure 48: US: Generic Injectables Market: Sales through Retail Pharmacy (in Million US$), 2015 & 2020
Figure 49: US: Generic Injectables Market Forecast: Sales through Retail Pharmacy (in Million US$), 2021-2026
Figure 50: Generic Injectables Manufacturing: Detailed Process Flow
Figure 51: Generic Injectables Manufacturing Process: Conversion Rate of Feedstock
Figure 52: Generic Injectables Manufacturing: Production Cost Breakup (in %)
Figure 53: Generic Injectables Manufacturing: Profit Margins at Various Levels of the Supply Chain
List of Tables
Table 1: Global: Generic Drug Market: Key Industry Highlights, 2020 and 2026
Table 2: US: Generic Drug Market: Key Industry Highlights, 2020 and 2026
Table 3: Global: Generic Injectables Market: Key Industry Highlights, 2020 and 2026
Table 4: US: Generic Injectables Market: Key Industry Highlights, 2020 and 2026
Table 5: US: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2021-2026
Table 6: US: Generic Injectables Market Forecast: Breakup by Container (in Million US$), 2021-2026
Table 7: US: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 8: US: Generic Injectables Market: Competitive Structure
Table 9: US: Generic Injectables Market: Key Players
Table 10: Generic Injectables Manufacturing Plant: Costs Related to Land and Site Development
Table 11: Generic Injectables Manufacturing Plant: Costs Related to Civil Works
Table 12: Generic Injectables Manufacturing Plant: Costs Related to Machinery Unit
Table 13: Generic Injectables Manufacturing Plant: Raw Material Requirements
Table 14: US: Generic Injectables Market: Competitive Structure
Table 15: US: Generic Injectables Market: Key Players